Overview of the phase I LuPARP study showing feasibility and recommended starting dose. (IMAGE)
Caption
Overview of the phase I LuPARP study showing feasibility and recommended starting dose.
Credit
Image created by by Elva Brynjarsdóttir, Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Usage Restrictions
Please give appropriate credit.
License
Original content